FDA Approved Medications For March 2026 Guideline Central January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification GHK Cu Peptide Regenerative & Cosmetic Research GHK Cu FDA Approval Status 2026: Not Approved GHK Cu Peptide Therapy Brea, CA Orange County